RF Based QIMT & QAS Study on Chinese Adults

September 13, 2021 updated by: Lijun Yuan, MD, PhD, Tang-Du Hospital

Reference Values of Carotid Intima-media Thickness and Arterial Stiffness in Chinese Adults Based on Ultrasound Radio Frequency Signal: A Nationwide, Multicenter Study

This study intends to establish the normal reference values of carotid artery intima-media thickness and vascular elasticity of Chinese adults based on ultrasound radio frequency technology through a multi-center large-sample study, which provides important information for the risk prediction and prognosis evaluation of Chinese adults' cardiovascular disease.

Study Overview

Detailed Description

After being informed about the study, all participants giving written informed consent will undergo a one-time examination of vascular ultrasound, including general characteristics and the target ultrasound parameters.

To detect the smallest difference between adjacent age groups within the age range 18-79 (6 groups, α = 0.05, β = 0.20, Statistical Power = 0.80). Given the influence of multiple centers, the minimum sample size is 1800, the optimal sample size is 3500. The male to female ratio is 1:1.

Quality Control including the pre-study training and data monitoring during the study.

Study Type

Observational

Enrollment (Anticipated)

3500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Anhui
      • Hefei, Anhui, China
        • Recruiting
        • The First Affiliated Hospital of Anhui Medical University
        • Contact:
          • Xianyue Yang
      • Hefei, Anhui, China
        • Recruiting
        • The Second Hospital of Anhui Medical University
        • Contact:
          • Jun Wu
      • Hefei, Anhui, China
        • Recruiting
        • The First Affiliated hospital of USTC
        • Contact:
          • Shuqing Jiang
    • Beijing
      • Beijing, Beijing, China
        • Recruiting
        • Air Force Medical Center
        • Contact:
          • Bin Ma
      • Beijing, Beijing, China
        • Recruiting
        • Beijing University of Chinese Medicine Third Affiliated Hospital
        • Contact:
          • Jingfang Dong
    • Guangdong
      • Guangzhou, Guangdong, China
        • Recruiting
        • Second Affiliated Hospital of Guangzhou Medical University
        • Contact:
          • Lin Mao
    • Guangxi
      • Nanning, Guangxi, China
        • Recruiting
        • First Affiliated Hospital of Guangxi Medical University
        • Contact:
          • Qiao Que
    • Guizhou
      • Guiyang, Guizhou, China
        • Recruiting
        • The Afffiliated Hospital of Guizhou Medical University
    • Hubei
      • Wuhan, Hubei, China
        • Recruiting
        • Renmin Hospital of Wuhan University
        • Contact:
          • Juhong Pan
      • Wuhan, Hubei, China
        • Recruiting
        • Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
        • Contact:
          • Yu Wu
    • Hunan
      • Changsha, Hunan, China
        • Recruiting
        • Third Xiangya Hospital of Central South University
        • Contact:
          • Wenhui Zhu
    • Inner Mongolia
      • Baotou, Inner Mongolia, China
        • Recruiting
        • The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology
        • Contact:
          • Shiji Wang
    • Jiangsu
      • Nanjing, Jiangsu, China
        • Recruiting
        • The First Affiliated Hospital with Nanjing Medical University
        • Contact:
          • Jianxiang Wang
    • Jilin
      • Changchun, Jilin, China
        • Recruiting
        • The First Hospital of Jilin University
        • Contact:
          • Na Su
    • Liaoning
      • Shenyang, Liaoning, China, 110004
        • Recruiting
        • Shengjing Hospital of China Medical University
        • Contact:
          • Xiaona Yu
      • Shenyang, Liaoning, China
        • Recruiting
        • First Hospital of China Medical University
        • Contact:
          • Huangliang Liu
    • Shandong
      • Qingdao, Shandong, China
        • Recruiting
        • The Affiliated Hospital of Qingdao University
        • Contact:
          • Yongmei Sun
    • Shanghai
      • Shanghai, Shanghai, China
        • Recruiting
        • Ruijin Hospital
        • Contact:
          • Ri Ji
    • Shannxi
      • Xi'an, Shannxi, China, 710038
        • Recruiting
        • Tangdu Hospital, Air Force Medical University
        • Contact:
          • Changyang Xing
      • Xi'an, Shannxi, China, 710068
        • Recruiting
        • Shannxi Provincial People's Hospital
        • Contact:
          • Aihua Wei
      • Xi'an, Shannxi, China
        • Recruiting
        • GEM Flower Xian Changqing Staff Hospital
        • Contact:
          • Hao Wang
      • Xi'an, Shannxi, China
        • Recruiting
        • Hospital of Northwestern Polytechnical University
        • Contact:
          • Fan Li
      • Xi'an, Shannxi, China
        • Recruiting
        • Second Affiliated Hospital of Xi'an JiaoTong University
        • Contact:
          • Ting Liu
      • Xi'an, Shannxi, China
        • Recruiting
        • The Second Affiliated Hospital of Xi'an Medical University
        • Contact:
          • Hengli Yang
      • Xi'an, Shannxi, China
        • Recruiting
        • Xi'an Central Hospital
        • Contact:
          • Xue Dong
      • Xi'an, Shannxi, China
        • Recruiting
        • Xi'an No.1 Hospital
        • Contact:
          • Xiaojun Zhan
    • Shanxi
      • Taiyuan, Shanxi, China
        • Recruiting
        • First Hospital of Shanxi Medical University
        • Contact:
          • Qianjun Ye
      • Xianyang, Shanxi, China
        • Recruiting
        • Xianyang Hospital of Yan'an University
        • Contact:
          • Bei Jia
    • Xijiang
      • Urumqi, Xijiang, China
        • Recruiting
        • General Hospital of Xinjiang Production and Construction Corps
        • Contact:
          • Ying Zhuang
    • Xinjiang
      • Karamay, Xinjiang, China
        • Recruiting
        • Karamay Central Hospital of Xinjiang
        • Contact:
          • Erke Zhang
      • Urumqi, Xinjiang, China
        • Recruiting
        • First Affiliated Hospital of Xinjiang Medical University
        • Contact:
          • Ting Ma
      • Urumqi, Xinjiang, China
        • Recruiting
        • The Fourth Affiliated Hospital of Xinjiang Medical University
        • Contact:
          • Zhanlei Chen
    • Yunnan
      • Kunming, Yunnan, China
        • Recruiting
        • Yan An Hospital Affiliated to Kunming Medical University
        • Contact:
          • Xuan Su
    • Zhejiang
      • Hangzhou, Zhejiang, China, 310012
        • Recruiting
        • The first Affiliated Hospital, Zhejiang University School of Medicine
        • Contact:
          • Xiujing Xie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 79 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy Han Chinese adults

Description

Inclusion Criteria:

  • Aged 18-79
  • The blood pressure is normal: systolic blood pressure <140 mmHg, and diastolic blood pressure <90 mmHg
  • The physical examination and electrocardiogram are normal

Exclusion Criteria:

  • Subjects with carotid intima-media thickness ≥ 1.0 mm should be excluded;
  • Subjects with previous cardiovascular disease history and medication history should be excluded. The main diseases include coronary heart disease, congenital heart disease, heart failure, hypertension, stroke, hyperlipidemia, diabetes, aortic arteritis, etc.;
  • Subjects with past medical history and medication history of endocrine, rheumatism, chronic respiratory disease, liver and kidney disease should be excluded;
  • Obese subjects (BMI ≥ 28 kg/m2), professional athletes, pregnant and lactating women should be excluded;
  • Alcohol or drug addicts and smokers who have not quit smoking should be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intima-media thickness
Time Frame: one-time measurement on the day of ultrasound examination
millimeter, one-time measurement throughout the study
one-time measurement on the day of ultrasound examination
Carotid stiffness index
Time Frame: one-time measurement on the day of ultrasound examination
=D▪ln(Ps/Pd)/ΔD, D: diastolic carotid diameter; Ps, systolic pressure; Pd, diastolic pressure; ΔD: Change of diameter in systolic. one-time measurement throughout the study
one-time measurement on the day of ultrasound examination
Pulse wave velocity
Time Frame: one-time measurement on the day of ultrasound examination
m/sec,one-time measurement throughout the study
one-time measurement on the day of ultrasound examination
Artery compliance coefficient
Time Frame: one-time measurement on the day of ultrasound examination
mm2kPa-1; =π▪(2▪D▪ΔD+ΔD2)/4▪ΔP; D: Diastolic diameter; ΔD: Change of diameter in systolic; ΔP, pulse pressure. one-time measurement throughout the study
one-time measurement on the day of ultrasound examination
Age
Time Frame: one-time measurement on the day of ultrasound examination
years, one-time measurement throughout the study
one-time measurement on the day of ultrasound examination

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood pressure
Time Frame: one-time measurement on the day of ultrasound examination
mmHg, one-time measurement throughout the study
one-time measurement on the day of ultrasound examination
fasting blood glucose
Time Frame: one-time measurement with 7 days before or after ultrasound examination
mmol/L, one-time measurement throughout the study
one-time measurement with 7 days before or after ultrasound examination
Total cholesterol
Time Frame: one-time measurement with 7 days before or after ultrasound examination
mmol/L, one-time measurement throughout the study
one-time measurement with 7 days before or after ultrasound examination
Triglycerides
Time Frame: one-time measurement with 7 days before or after ultrasound examination
mmol/L, one-time measurement throughout the study
one-time measurement with 7 days before or after ultrasound examination
Height
Time Frame: one-time measurement on the day of ultrasound examination
m, one-time measurement throughout the study
one-time measurement on the day of ultrasound examination
Weight
Time Frame: one-time measurement on the day of ultrasound examination
kg, one-time measurement throughout the study
one-time measurement on the day of ultrasound examination

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Lijun Yuan, PhD; MD, Tangdu Hospital, Air Force Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Anticipated)

May 1, 2022

Study Completion (Anticipated)

May 1, 2022

Study Registration Dates

First Submitted

May 1, 2021

First Submitted That Met QC Criteria

May 5, 2021

First Posted (Actual)

May 11, 2021

Study Record Updates

Last Update Posted (Actual)

September 14, 2021

Last Update Submitted That Met QC Criteria

September 13, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 20210402V2.0

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD that underlie results in a publication

IPD Sharing Time Frame

starting 6 months after publication

IPD Sharing Access Criteria

Access is provided after a research proposal is submitted and has received approval from the Independent Review Panel and after a Data Sharing Agreement is in place

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Subscribe